Literature DB >> 7479557

Monoclonal digoxin-specific antibodies induce dose- and affinity-dependent plasma digoxin redistribution in rats.

N J Cano1, A E Sabouraud, K Benmoussa, F Roquet, I Navarro-Teulon, J C Mani, J M Scherrmann.   

Abstract

The effect of three monoclonal digoxin-specific antibodies on total and free digoxin plasma disposition was studied in rats in order to determine the role of affinity constant (Ka) and dose. Thirty minutes after digoxin infusion, administration of a stoichiometrical dose of the ICIO, 6C9 and 9F5 IgG (Ka = 6 10(9), 3.1 10(8) and 2.5 10(7) M-1, respectively) resulted in a plasma digoxin increase linearly related to Ka. The mean free plasma digoxin was 0.6 +/- 0.4, 7.8 +/- 3.3 and 43 +/- 22% respectively after 1C10, 6C9, and 9F5 IgG infusion in comparison to 70 +/- 9% in the control group. When the IgG:digoxin ratio increased from 1 to 5, plasma digoxin Cmax and AUCT also increased as a function of both affinity (Ka) and dose (N), but not linearly. The product of NKa defined an immunoreactivity factor that was well fitted to the digoxin redistribution parameters (Cmax and AUCT) by a Hill equation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479557     DOI: 10.1023/a:1016211626095

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies.

Authors:  T W Smith; E Haber; L Yeatman; V P Butler
Journal:  N Engl J Med       Date:  1976-04-08       Impact factor: 91.245

2.  Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication.

Authors:  W Schaumann; B Kaufmann; P Neubert; A Smolarz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 3.  Reversal of the pharmacological and toxic effects of cardiac glycosides by specific antibodies.

Authors:  V P Butler; J F Watson; D H Schmidt; J D Gardner; W J Mandel; C L Skelton
Journal:  Pharmacol Rev       Date:  1973-06       Impact factor: 25.468

4.  Redistribution into plasma of tracer doses of desipramine by anti-desipramine antiserum in rats.

Authors:  P Pentel; S M Pond; D Schoof
Journal:  Biochem Pharmacol       Date:  1987-01-15       Impact factor: 5.858

5.  Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.

Authors:  P R Pentel; D E Keyler; G J Brunn; J M Milavetz; D G Gilbertson; S G Matta; S M Pond
Journal:  Drug Metab Dispos       Date:  1991 Jan-Feb       Impact factor: 3.922

6.  Reversal of advanced colchicine toxicity in mice with goat colchicine-specific antibodies.

Authors:  N Terrien; M Urtizberea; J M Scherrmann
Journal:  Toxicol Appl Pharmacol       Date:  1990-07       Impact factor: 4.219

7.  Effects of alpha-1-acid glycoprotein administration on propranolol binding and beta blockade in rats.

Authors:  D E Keyler; P R Pentel
Journal:  Biochem Pharmacol       Date:  1989-04-01       Impact factor: 5.858

8.  Analytical control procedures of immunoreactivity for IgG and Fab fragments specific to haptens.

Authors:  N J Cano; A E Sabouraud; M Urtizberea; J Carcagne; M Grandgeorge; J M Scherrmann
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

9.  Reversal of lethal digoxin toxicity in guinea pigs using monoclonal antibodies and Fab fragments.

Authors:  P Lechat; M Mudgett-Hunter; M N Margolies; E Haber; T W Smith
Journal:  J Pharmacol Exp Ther       Date:  1984-04       Impact factor: 4.030

10.  Determination of the in vivo antigen-antibody affinity constant from the redistribution of desipramine in rats following administration of a desipramine-specific monoclonal antibody.

Authors:  S M Pond; P R Pentel; D E Keyler; D J Winzor
Journal:  Biochem Pharmacol       Date:  1991-02-01       Impact factor: 5.858

View more
  2 in total

1.  Facilitation of imipramine efflux from the brain by systemic specific antibodies.

Authors:  C Ragusi; G Boschi; R Rips; J M Scherrmann
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

2.  Design of cocaethylene and cocaine conjugates to produce highly selective polyclonal antibodies.

Authors:  Caroline Gadjou; Yannic Danger; Pierre Sandouk; Jean-Michel Scherrmann; Dominique Blanchard; Gilles Folléa; Hervé Galons
Journal:  Int J Biomed Sci       Date:  2006-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.